CJ Bioscience, Inc. (KOSDAQ: 311690)

CJ Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	104,703	147,076	170,481	286,048	199,288	143,216
Market Cap Growth	-15.44%	-13.73%	-40.40%	43.53%	39.15%	-
Enterprise Value	63,854	116,989	139,502	291,080	185,214	129,115
Last Close Price	11490.00	16140.00	24887.51	41793.85	43939.33	32267.94
PE Ratio	-	-4.99	-4.19	-9.22	-19.36	-24.50
PS Ratio	20.40	26.38	41.84	65.56	37.52	29.94
PB Ratio	1.87	2.06	3.43	3.26	5.78	4.64
P/FCF Ratio	-4.35	-4.93	-6.79	-30.46	-9.97	-48.82
P/OCF Ratio	-4.54	-5.91	-8.13	-33.90	-24.98	-57.15
EV/Sales Ratio	13.03	20.98	34.24	66.72	34.87	26.99
EV/EBITDA Ratio	-2.57	-4.35	-4.76	-34.06	-24.82	-34.09
EV/EBIT Ratio	-2.18	-3.65	-4.20	-28.80	-21.76	-28.57
EV/FCF Ratio	-2.44	-3.92	-5.56	-31.00	-9.26	-44.02
Debt / Equity Ratio	0.16	0.12	0.58	0.27	1.04	0.02
Debt / FCF Ratio	-0.34	-0.29	-1.15	-2.54	-1.79	-0.25
Asset Turnover	0.07	0.06	0.04	0.05	0.10	0.21
Inventory Turnover	19.97	32.50	24.89	10.67	13.27	17.34
Quick Ratio	3.44	4.38	1.43	3.39	13.19	13.57
Current Ratio	3.53	4.43	1.46	3.42	13.68	13.73
Return on Equity (ROE)	-47.56%	-37.83%	-50.78%	-31.51%	-26.82%	-20.88%
Return on Assets (ROA)	-25.83%	-21.95%	-20.00%	-6.66%	-9.94%	-12.13%
Return on Capital (ROIC)	-30.21%	-25.26%	-21.82%	-6.94%	-10.45%	-13.33%
Earnings Yield	-21.18%	-15.58%	-20.48%	-6.74%	-4.40%	-3.03%
FCF Yield	-25.04%	-20.28%	-14.73%	-3.28%	-10.03%	-2.05%
Buyback Yield / Dilution	-47.97%	-20.52%	-38.23%	-10.14%	-16.93%	-2.78%
Total Shareholder Return	-47.97%	-20.52%	-38.23%	-10.14%	-16.93%	-2.78%

Source: S&P Capital IQ. Standard template. Financial Sources.